TSC2 and Angiofibroma: An inactivating TSC2 c.1331del, p.(Asn444Thrfs∗5) variant (VAF 3%) was identified in genomic DNA isolated from the angiofibroma but was absent from genomic DNA isolated from blood (Table 3) and is, therefore, likely to be a lesion-specific, second-hit mutation.